Diltiazem pharmaceutical spheroid formulation
US5508044A · kind A · utility
11Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1994 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | Jul 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid oral dosage form comprising diltiazem (or a pharmaceutically acceptable salt thereof) in controlled release form and hydrochlorothiazide in immediate release form. Preferably, the controlled release component comprises a plurality of spheroids comprising diltiazem and a spheronizing agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.